These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24548256)

  • 41. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
    Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
    Biomed Pharmacother; 2019 Oct; 118():109206. PubMed ID: 31306972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.
    Ivashkin V; Poluektov Y; Kogan E; Shifrin O; Sheptulin A; Kovaleva A; Kurbatova A; Krasnov G; Poluektova E
    PLoS One; 2021; 16(6):e0252930. PubMed ID: 34115808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
    O'Malley D; Quigley EM; Dinan TG; Cryan JF
    Brain Behav Immun; 2011 Oct; 25(7):1333-41. PubMed ID: 21536124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Chen CY; Zhang M; Wang SS; Lü B; Wang X
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(14):1065-1070. PubMed ID: 28395430
    [No Abstract]   [Full Text] [Related]  

  • 46. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
    Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G
    Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is irritable bowel syndrome a low-grade inflammatory bowel disease?
    Bercik P; Verdu EF; Collins SM
    Gastroenterol Clin North Am; 2005 Jun; 34(2):235-45, vi-vii. PubMed ID: 15862932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences.
    Barbara G; Cremon C; Stanghellini V
    Curr Opin Gastroenterol; 2014 Jul; 30(4):352-8. PubMed ID: 24811054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].
    Piche T
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S40-7. PubMed ID: 19303538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: Can gluten contribute to irritable bowel syndrome?
    Verdu EF
    Am J Gastroenterol; 2011 Mar; 106(3):516-8. PubMed ID: 21378766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.
    Wu RL; Vazquez-Roque MI; Carlson P; Burton D; Grover M; Camilleri M; Turner JR
    Lab Invest; 2017 Jan; 97(1):14-23. PubMed ID: 27869798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
    Hyland NP; Quigley EM; Brint E
    World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
    Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-16 inhibits the TLR4/NF-κB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
    Xi M; Zhao P; Li F; Bao H; Ding S; Ji L; Yan J
    J Biol Chem; 2022 Nov; 298(11):102461. PubMed ID: 36067883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K; Róka R; Ferrier L; Leveque M; Eutamene H; Cartier C; Ait-Belgnaoui A; Rosztóczy A; Izbéki F; Fioramonti J; Wittmann T; Bueno L
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.